In gene therapy, it is necessary that the development of delivery vehicles or vectors can selectively deliver therapeutic genes to target cells safely and with high efficiency. There are two main approaches in gene delivery, viral gene delivery and non-viral gene delivery. Although viral vector have high transfection efficiencies over a wide range of cell targets, they have major limitations, including virally-induced inflammatory responses and oncogenic effects.1,2) Non-viral vectors, which are generally delivered as a complex with chemical and/or biochemical vectors such as cationic lipids or polymers, continue to be an attractive alternative to viral vectors due to their safety, versatility, and ease of preparation and scale-up. Non-viral vectors, however, generally suffer from relatively low transfection efficiencies. 3,4) Selective gene therapy approaches have been considered as a promising cure for various cancers. Therefore, it is necessary to develop delivery vehicles that can selectively deliver therapeutic genes to target cancer cells safely and with high efficiency. Several different targeting moieties have been used in studies on cancer gene therapy, such as transferrin, folate, anisamide, RGD-peptide, and antibodies. [5][6][7][8][9][10] In this context, the present study focused on AG73 peptide, which is 12 amino acid synthetic peptide derived from the globular domain of the laminin a1 chain. AG73 peptide is as a ligand for syndecans, one of the major heparin sulfatecontaining transmembrane protein.11-13) It has been reported that syndecan-2 is highly expressed in various cancer cells and play a role in angiogenesis. [14][15][16][17][18] Therefore, AG73-labeled polyethyleneglycol-modified liposomes (AG73-PEG liposomes) were prepared, which were capable of encapsulating a gene condensed by poly-L-lysine.In this study, we assessed the characterization and transfection efficiency of prepared AG73-PEG liposomes. To confirm the conjugation of AG73 peptide to liposomes and the morphology of AG73-PEG liposomes, we performed highperformance liquid chromatography (HPLC) analysis and electron microscopy observation. Furthermore, we examined whether AG73-PEG liposomes can deliver genes to cells selectively via syndecan-2.
MATERIALS AND METHODS
MaterialsThe plasmid pCytomegalovirus (CMV)-Luc is an expression vector encoding the firefly luciferase gene under the control of a cytomegalovirus promoter.Cell Lines and Cultures A 293T human embryonic kidney carcinoma cell line, stably overexpressing syndecan-2 (293T-Syn2), was cultured in Dulbecco's modified Eagle's medium (DMEM; Kohjin Bio Co., Ltd., Tokyo, Japan), supplemented with 10% fetal bovine serum (FBS; Equitech Bio Inc., Kerrville, TX, U.S.A.), penicillin (100 U/ml), Streptomycin (100 mg/ml), and puromycin (0.4 mg/ml), at 37°C in an humidified 5% CO 2 atmosphere.Preparation of AG73-PEG Liposomes The Cys-AG73 peptide (CGG-RKRLQVQLSIRT) and scrambled Cys-AG73T control peptide (CGG-LQQRRSVLRTKI) were synthesized manually using the 9-fluorenylmethoxycarbonyl (F...